Bausch Health Companies
Price & Volume
Stats
See moreOpen | $6.77 |
Previous Close | $6.81 |
Day Range | $6.72-$6.87 |
52W Range | $4.25-$9.85 |
Market Cap | $2.5B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $9.8B |
Revenue Growth (YoY) | 5.3% |
Gross Profit (12 Mos) | $6.9B |
Diluted EPS | $0.26 |
News
See moreYahoo Finance • 3 days ago
How the FDA Is Taking Aim at the Surreal World of TV Drug Ads
Yahoo Finance • 7 days ago
Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis
Yahoo Finance • 14 days ago
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL
Yahoo Finance • 26 days ago
Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition
About
CEO | Mr. Thomas J. Appio |
CFO | Mr. Jean-Jacques Charhon |
Address | 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 20,700 |
